Unknown

Dataset Information

0

Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat.


ABSTRACT: Histone deacetylases (HDAC) are frequently overexpressed in tumors, and their inhibition has shown promising anti-tumor effects. However, the synergistic effects of HDAC inhibition with immune cell therapy have not been fully explored. Natural killer (NK) cells are cytotoxic lymphocytes for anti-tumor immune surveillance, with immunotherapy potential. We showed that a pan-HDAC inhibitor, panobinostat, alone demonstrated anti-tumor and anti-proliferative activities on all tested tumors in vitro. Additionally, panobinostat co-treatment or pretreatment synergized with NK cells to mediate tumor cell cytolysis. Mechanistically, panobinostat treatment increased the expression of cell adhesion and tight junction-related genes, promoted conjugation formation between NK and tumor cells, and modulates NK cell-activating receptors and ligands on tumor cells, contributing to the increased tumor cytolysis. Finally, panobinostat therapy led to better tumor control and synergized with anti-PD-L1 therapy. Our data highlights the anti-tumor potential of HDAC inhibition through tumor-intrinsic toxicity and enhancement of NK -based immunotherapy.

SUBMITTER: Afolabi LO 

PROVIDER: S-EPMC8438531 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3355195 | biostudies-literature
| S-EPMC4682236 | biostudies-literature
| S-EPMC5593556 | biostudies-literature
| S-EPMC4503685 | biostudies-literature
| S-EPMC8437887 | biostudies-literature
| S-EPMC2890707 | biostudies-literature
| S-EPMC3923253 | biostudies-literature
| S-EPMC7611632 | biostudies-literature
| S-EPMC4599239 | biostudies-literature
| S-EPMC6255162 | biostudies-literature